EXACT Therapeutics AS (OSL:EXTX)

Norway flag Norway · Delayed Price · Currency is NOK
2.960
+0.060 (2.07%)
At close: Jul 10, 2025
-62.77%
Market Cap 187.26M
Revenue (ttm) n/a
Net Income (ttm) -52.33M
Shares Out 63.26M
EPS (ttm) -1.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 290
Average Volume 32,022
Open 2.960
Previous Close 2.900
Day's Range 2.960 - 2.960
52-Week Range 2.300 - 7.950
Beta 0.19
RSI 55.71
Earnings Date Sep 10, 2025

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 12
Stock Exchange Oslo Børs
Ticker Symbol EXTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.